Advanced Biomedical Technologies, Inc.

ABMT · OTC
Analyze with AI
7/31/2022
4/30/2022
1/31/2022
10/31/2021
Operating Activities
Net Income-$190-$190$58-$170
Dep. & Amort.$3$7$7$7
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$16-$234$33
Other Non-Cash$17$3$7$33
Operating Cash Flow-$170-$197-$162-$97
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$137$131
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$148$218-$4-$4
Financing Cash Flow$148$218$134$127
Forex Effect$0$0$0$0
Net Chg. in Cash-$23$21$0$0
Supplemental Information
Beg. Cash$29$8$37$7
End Cash$6$29$8$37
Free Cash Flow-$170-$197-$162-$97
Advanced Biomedical Technologies, Inc. (ABMT) Financial Statements & Key Stats | AlphaPilot